EditorialProspective Validation of Active Surveillance in Prostate Cancer: The PRIAS Study
Section snippets
Funding
Department of Urology Erasmus Medical Center Rotterdam, The Netherlands.
Prostate Cancer Research Foundation (SWOP) Rotterdam, The Netherlands.
References (21)
- et al.
The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study
J Urol
(1999) - et al.
Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results
Urol Oncol
(2006) Watching the face of Janus – active surveillance as a strategy to reduce overtreatment for localised prostate cancer
Eur Urol
(2006)- et al.
Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome
Eur Urol
(2007) - et al.
Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance
Eur Urol
(2006) - et al.
Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium
Urology
(2001) - et al.
Nonpalpable stage T1C prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings
J Urol
(1998) - et al.
Prospective evaluation of men with stage T1C adenocarcinoma of the prostate
J Urol
(1997) - et al.
Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease
J Urol
(2001) - et al.
A model for the number of cores per prostate biopsy based on patient age and prostate gland volume
J Urol
(1998)
There are more references available in the full text version of this article.
Cited by (216)
Improvement of PI-RADS-dependent prostate cancer classification by quantitative image assessment using radiomics or mean ADC
2021, Magnetic Resonance Imaging
Copyright © 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved.